Barclays’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,046,200
Closed -$130M 7986
2013
Q3
$130M Buy
1,046,200
+684,200
+189% +$86.6M 0.15% 92
2013
Q2
$31.4M Buy
+362,000
New +$33.3M 0.04% 419

Barclays's ONXX Position: Q4 2013 in Review

Barclays sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 1,553,089 shares — an estimated $193M sold.

Barclays first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $193M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Barclays reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Barclays sold 1,553,089 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $193M.
  • Barclays first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Barclays's ONYX PHARMACEUTICALS INC position peaked at $193M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.